Search Editorial Photos
"type 2 diabetes"
16 professional editorial images found
#11132625
9 April 2024
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11132626
9 April 2024
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11132629
9 April 2024
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11132630
9 April 2024
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11132624
9 April 2024
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11130122
8 April 2024
Novo Nordisk Wegovy manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 8, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10835048
7 December 2023
Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10835052
7 December 2023
Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10835050
7 December 2023
Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10835051
7 December 2023
Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10835054
7 December 2023
Ozempic manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on December 7, 2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798155
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798149
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798152
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798146
19 November 2023
A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798141
19 November 2023
A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.